The drops go beyond the pandemic and cut across income, geographic and racial divides, new data shows. By Claire Cain Miller Francesca Paris and Sarah Mervosh Something troubling is happening in U.S.

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Here's the revised video description with all the links and additional text removed: --- Learn how to graph quadratics in standard form. A quadratic equation is an equation whose highest exponent in ...

Waterloo scientists have developed a new way to understand how the universe began, and it could change what we know about the Big Bang and the earliest moments of cosmic history. Their work suggests ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

OpenAI is rolling out new interactive responses in ChatGPT it says are designed to make the chatbot more useful for learners. Starting today, ChatGPT will generate dynamic visuals when you ask it to ...

On Tuesday, OpenAI introduced dynamic visual explanations, a new ChatGPT feature that allows users to see how formulas, variables, and mathematical relationships change in real time. Instead of just ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...